Latest VMD reports update at 2024-05-06: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Viemed Healthcare VMD

$ 7.13 -1.93%

Viemed Healthcare Balance Sheet 2011-2024 | VMD

Annual Balance Sheet Viemed Healthcare

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-22.6 M	-23.3 M	-3.98 M	-6.99 M	81 K	2.15 M	-	-	-	-	-
Long Term Debt	6 M	-	4.31 M	5.8 M	7.63 M	-	-	-	-	-	-	-	-
Long Term Debt Current	678 K	495 K	1.48 M	1.84 M	1.75 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	8.88 M	1.09 M	5.33 M	7.85 M	13 M	1.51 M	798 K	2.63 M	-	-	-	-	-
Total Current Liabilities	32.1 M	18.9 M	17.8 M	23 M	25.9 M	-	-	-	-	-	-	-	-
Total Liabilities	41 M	19.9 M	23.1 M	30.9 M	38.9 M	18.5 M	13.9 M	11.8 M	-	-	-	-	-
Deferred Revenue	6.21 M	4.62 M	3.75 M	3.41 M	3.32 M	-	-	-	-	-	-	-	-
Retained Earnings	79.5 M	69.8 M	73.3 M	65.6 M	34.1 M	29.6 M	21 M	12.8 M	-	-	-	-	-
Total Assets	155 M	117 M	118 M	113 M	82.6 M	53.5 M	37.7 M	24.7 M	-	-	-	-	-
Cash and Cash Equivalents	12.8 M	16.9 M	28.4 M	31 M	13.4 M	10.4 M	-	-	-	-	-	-	-
Book Value	114 M	97.1 M	94.8 M	81.7 M	43.7 M	35 M	23.7 M	12.9 M	-	-	-	-	-
Total Shareholders Equity	114 M	97.1 M	94.8 M	81.7 M	43.7 M	32.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Viemed Healthcare

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5.91 M	6 M	8.1 M	12.1 M	-	-	4.16 M	-	4.27 M	4.31 M	4.35 M	4.85 M	5.32 M	5.8 M	5.8 M	5.8 M	5.8 M	7.63 M	7.63 M	7.63 M	7.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	8.48 M	8.88 M	9.03 M	13 M	1.17 M	1.09 M	4.95 M	-	5.23 M	5.33 M	5.91 M	6.43 M	7.72 M	7.85 M	7.85 M	7.85 M	7.85 M	13 M	13 M	13 M	13 M	1.51 M	1.51 M	1.51 M	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	38.6 M	41 M	40.6 M	44.6 M	24.6 M	19.9 M	25.5 M	-	23 M	23.1 M	26.1 M	24.8 M	29.6 M	30.9 M	30.9 M	30.9 M	30.9 M	38.9 M	38.9 M	38.9 M	38.9 M	21.1 M	18.5 M	18.5 M	15.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	6.09 M	6.21 M	6.22 M	5.96 M	4.7 M	4.62 M	4.64 M	-	3.89 M	3.75 M	3.8 M	3.74 M	3.42 M	3.41 M	3.41 M	3.41 M	3.41 M	3.32 M	3.32 M	3.32 M	3.32 M	2.59 M	2.48 M	2.27 M	2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	80.1 M	79.5 M	76 M	73.2 M	70.9 M	69.8 M	68.1 M	-	73.1 M	73.3 M	69.2 M	67.5 M	65.9 M	65.6 M	65.6 M	65.6 M	65.6 M	34.1 M	34.1 M	34.1 M	34.1 M	27.1 M	29.6 M	29.6 M	21.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	155 M	155 M	149 M	149 M	125 M	117 M	119 M	-	119 M	118 M	115 M	111 M	113 M	113 M	113 M	113 M	113 M	82.6 M	82.6 M	82.6 M	82.6 M	53.7 M	53.5 M	53.5 M	40.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	7.31 M	12.8 M	10.1 M	10.2 M	23.5 M	16.9 M	21.5 M	21.9 M	29.2 M	28.4 M	26.9 M	31.2 M	31.1 M	31 M	31 M	31 M	31 M	13.4 M	13.4 M	13.4 M	13.4 M	10.4 M	10.4 M	10.4 M	4.63 M	5.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	116 M	114 M	109 M	105 M	100 M	97.1 M	93.9 M	-	96 M	94.8 M	89.4 M	86.3 M	83.4 M	81.7 M	81.7 M	81.7 M	81.7 M	43.7 M	43.7 M	43.7 M	43.7 M	32.6 M	35 M	35 M	24.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	116 M	114 M	109 M	105 M	100 M	97.1 M	93.9 M	93.2 M	96 M	94.8 M	89.4 M	86.3 M	83.4 M	81.7 M	81.7 M	81.7 M	81.7 M	43.7 M	43.7 M	43.7 M	43.7 M	32.6 M	35 M	35 M	24.7 M	22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency